Optum moves forward in $3.3B deal: What ASCs need to know 

Earlier this month, Amedisys shareholders approved a $3.3 billion acquisition by Optum. 

Here's what ASCs need to know:

1. There were more than 25 million votes in favor — 30,000 against and 67,000 abstensions. 
2. Optum announced plans to merge with Baton Rouge, La.-based home and hospice care provider in June. 
3. The deal is facing scrutiny from the Justice Department, which requested additional information about the proposed merger in August. Additionally, the department extended the waiting period for the deal under federal law.
4. An Amedisys stockholder also filed a lawsuit against the company in August — seeking to stop the purchase and alleging that directors misrepresented key information in a proxy statement related to the proposed acquisition.